Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Study casts doubt on potential for life on Jupiter's moon Europa - 2Canada Awards C$1.5 Billion Defense Contracts to L3Harris, Airbus
- 3The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- 4Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now.
- 5Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use
- Pleasant Cycle Courses All over the Planet
- Dear Santa: I want Botox. Why cosmetic procedures are topping holiday wish lists.
- Louisiana seeks California doctor’s extradition, testing the limits of shield laws
- Kansas school officials report high student illness, dismiss early
- Broken toilet, T-shirts on windows and collecting saliva: The weirdness of daily life aboard Orion
- Find the Effect of Web-based Entertainment on Psychological wellness: Exploring the Advanced Scene Securely
- Carina Nebula shines with white-blue stars | Space photo of the day for Jan. 5, 2026
- Figure out How to Store Your Gold Ventures: A Thorough Aide safely
- 'An incredible privilege and responsibility': Artemis 2's Christina Koch is ready to become the 1st woman to fly around the moon
